# NuraNavX

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/nuranavx

- Industry: Healthcare
- Headquarters: Shenzhen, China
- Website: www.xijiabrainmap.com/
- Latest round: Angel (May 26, 2025)
- Investors on record: 1

## About

NuraNavX, based in Shenzhen, China, specializes in cutting-edge medical technology focused on advanced diagnostic tools and cognitive assessment software to enhance healthcare outcomes.Founded in 2020, NuraNavX operates in Shenzhen, China, developing innovative solutions in medical technology. The company was formed by individuals with backgrounds in the healthcare and technology sectors, with a single deal recorded to date. The latest funding round occurred on May 26, 2025, where NuraNavX raised an undisclosed amount of Angel funding from K2 Venture Partners.Shenzhen Xijia Medical Technology Co., Ltd. specializes in the development and deployment of advanced medical technology solutions aimed at improving healthcare outcomes. The company's core product offerings include innovative diagnostic tools and software platforms that facilitate brain mapping and cognitive assessment. These technologies are designed to address specific clinical needs, such as enhancing the precision of neurological diagnoses and tailoring therapeutic approaches for patients with cognitive impairments. Shenzhen Xijia Medical serves a diverse client base, including hospitals, specialized clinics, and research institutions across markets in Asia, Europe, and North America, ensuring wide accessibility of their products to healthcare providers and end users seeking advanced medical intervention.Shenzhen Xijia Medical's revenue model is anchored in a combination of direct sales and strategic partnerships within the healthcare sector. The company engages in B2B transactions, supplying its diagnostic tools and software solutions to healthcare providers, which are essential for effective patient management. Revenue is generated primarily through sales of flagship products, alongside subscription services for software updates and technical support. Specific pricing structures are tailored to the needs of clients, reflecting the value of the technology and support services provided. By fostering partnerships with hospitals and clinics, the company enhances its market presence and customer engagement, contributing to its financial sustainability.In May 2025, NuraNavX raised an undisclosed amount of Angel funding from K2 Venture Partners. The company plans to utilize this funding for marketing and advancing research and development of AI brain connectomics products. Future initiatives include launching new diagnostic tools tailored for cognitive assessment, with specific release dates aimed for late 2025. NuraNavX is also focusing on expanding into new markets, particularly targeting Europe and North America, by the end of 2026.

## Funding rounds

- Angel, May 26, 2025 — K2 Venture Partners

## Investors

- K2 Venture Partners — Angel